体外生命支持作为肺移植桥接——高容量移植中心的经验
该病例系列回顾了某高容量中心2006年1月至2016年9月间1111例肺移植中71例以体外生命支持(ECLS)桥接至肺移植的成人患者,63例(89%)存活至移植,意向治疗1年、3年、5年生存率分别为66%、58%、48%;桥接至再移植者生存显著短于首次移植。
要点
- ECLS桥接至首次肺移植在仔细筛选的患者中可获得良好的短期和长期结局。
- 桥接至再移植的中位生存15个月(95%CI 0-31) vs 首次移植60个月(95%CI 37-83),P=0.041。
- ECLS桥接至再移植应谨慎使用(作者建议)。
核心结论
- 在该中心经验中,ECLS桥接至首次肺移植在仔细筛选的患者中带来良好的短期和长期结局。
- 作者认为,ECLS作为桥接至再移植的手段应谨慎使用。
研究设计与样本
- 病例系列,纳入所有以桥接至肺移植为目的接受ECLS的成人患者,数据来自患者病历及本机构ECLS和移植数据库。
- 2006年1月至2016年9月,本机构共实施1111例肺移植,其中71例成人以ECLS桥接至肺移植,11例(16%)桥接至再移植。
主要发现
- ECLS至肺移植的中位持续时间为10天(范围0-95)。
- 23例(32%)使用单根双腔静脉插管;13例肺动脉高压患者中9例(69%)通过中心肺动脉至左心房Novalung桥接。
- 25例(35%)在ECLS期间拔管,26例(37%)进行了活动。
- 63例(89%)存活至肺移植;意向治疗生存率1年66%、3年58%、5年48%。
- 桥接至再移植者生存显著短于首次肺移植者:中位生存15个月(95%CI 0-31) vs 60个月(95%CI 37-83),P=0.041。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Extracorporeal life support (ECLS) is increasingly used to bridge deteriorating patients awaiting lung transplantation (LTx), however, few systematic descriptions of this practice exist. We therefore aimed to review our institutional experience over the past 10 years. METHODS: In this case series, we included all adults who received ECLS with the intent to bridge to LTx. Data were retrieved from patient charts and our institutional ECLS and transplant databases. RESULTS: Between January 2006 and September 2016, 1111 LTx were performed in our institution. ECLS was used in 71 adults with the intention to bridge to LTx; of these, 11 (16%) were bridged to retransplantation. The median duration of ECLS before LTx was 10 days (range, 0-95). We used a single dual-lumen venous cannula in 23 patients (32%). Nine of 13 patients (69%) with pulmonary hypertension were bridged by central pulmonary artery to left atrium Novalung. Twenty-five patients (35%) were extubated while on ECLS and 26 patients (37%) were mobilized. Sixty-three patients (89%) survived to LTx. Survival by intention to treat was 66% (1 year), 58% (3 years) and 48% (5 years). Survival was significantly shorter in patients undergoing ECLS bridge to retransplantation compared with first LTx (median survival, 15 months (95% CI, 0-31) versus 60 months (95% CI, 37-83); P = .041). CONCLUSIONS: In our center experience, ECLS bridge to first lung transplant leads to good short-term and long-term outcomes in carefully selected patients. In contrast, our data suggest that ECLS as a bridge to retransplantation should be used with caution.
引用
- Hoetzenecker K, Donahoe L, Yeung JC, et al. Extracorporeal life support as a bridge to lung transplantation-experience of a high-volume transplant center. J Thorac Cardiovasc Surg. 2017. PMID: 29248282. doi:10.1016/j.jtcvs.2017.09.161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。